Section Arrow
NSPR.NASDAQ
- InspireMD
Quotes are at least 15-min delayed:2025/06/28 14:56 EDT
Last
 2.29
+0.03 (+1.33%)
Day High 
2.295 
Prev. Close
2.26 
1-M High
2.65 
Volume 
168.36K 
Bid
2.17
Ask
2.26
Day Low
2.16 
Open
2.24 
1-M Low
1.99 
Market Cap 
69.24M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.41 
20-SMA 2.46 
50-SMA 2.47 
52-W High 3.798 
52-W Low 1.99 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.77/-0.94
Enterprise Value
71.03M
Balance Sheet
Book Value Per Share
0.93
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.01M
Operating Revenue Per Share
0.18
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 14:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNetand a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.